Tigard Peptide Therapy Clinic

Tigard Peptide Therapy Clinic operates as a telehealth-focused men's health practice serving patients throughout Oregon with specialized expertise in andrology, urology, and peptide-based interventions for sexual dysfunction and age-related decline. The clinic's virtual consultation model allows Oregon residents to access peptide therapy protocols without geographic limitations, while maintaining continuity of care through secure video platforms and coordinated laboratory monitoring. With a 4.8-star rating across 154 patient reviews, the practice has established a reputation for addressing complex hormonal imbalances and sexual health concerns through evidence-based peptide applications rather than relying solely on conventional hormone replacement approaches.

Tigard Peptide Therapy Clinic offers a range of peptide therapy options tailored to individual patient needs. Treatment protocols are customized based on health goals, lab work, and medical history, with options for hormone optimization, metabolic health, tissue repair, and performance enhancement.

The clinical team includes providers with credentials in urology and men's health who conduct thorough telehealth evaluations that address underlying causes of sexual dysfunction, including vascular insufficiency, neurogenic factors, and psychological components that may benefit from peptide adjuncts. Initial consultations involve detailed medical history review, medication reconciliation to identify drugs contributing to erectile dysfunction or libido suppression, and discussion of realistic treatment timelines—patients typically begin noticing improvements in sexual function within 2-4 weeks of PT-141 initiation, while tissue repair peptides like BPC-157 require 8-12 weeks for measurable structural changes. The clinic's approach emphasizes patient education on peptide administration techniques, with video tutorials provided for subcutaneous injection protocols and guidance on reconstitution of lyophilized peptides for those new to self-administration.

Patients engaging with Tigard Peptide Therapy Clinic can expect a structured onboarding process that begins with a telehealth intake appointment lasting 45-60 minutes, during which providers review symptoms, order baseline laboratory work through Oregon-based partner facilities, and establish treatment goals specific to sexual performance, muscle composition, or metabolic health. Follow-up consultations occur at 4-6 week intervals during the initial three months to assess peptide response through both subjective reports and objective markers such as repeat testosterone levels, IGF-1 measurements, or validated questionnaires like the International Index of Erectile Function. The clinic coordinates peptide sourcing through FDA-registered compounding pharmacies that provide certificates of analysis for peptide purity, and patients receive detailed protocols outlining dosing schedules, storage requirements at 2-8°C, and reconstitution instructions. For men addressing multiple concerns—such as concurrent erectile dysfunction and low energy—the clinic designs combination protocols that may include morning administration of growth hormone secretagogues and evening dosing of PT-141 prior to anticipated sexual activity.

The telehealth delivery model positions Tigard Peptide Therapy Clinic as an accessible option for Oregon men who face barriers to in-person urology or andrology care, whether due to rural residence, scheduling constraints, or preference for privacy when discussing sexual health concerns. The clinic maintains collaborative relationships with local urologists in the Portland metropolitan area for patients requiring procedural interventions or diagnostic testing beyond the scope of telehealth, ensuring continuity when peptide therapy is used as an adjunct to surgical treatments for conditions like varicocele or as preparation for penile implant procedures. This integrated approach allows the practice to serve as both a primary peptide therapy provider and a consultative resource for men seeking alternatives to phosphodiesterase-5 inhibitors, intracavernosal injections, or testosterone replacement therapy that may not align with fertility preservation goals.